期刊
JOURNAL OF PHARMACOLOGICAL SCIENCES
卷 138, 期 4, 页码 257-262出版社
JAPANESE PHARMACOLOGICAL SOC
DOI: 10.1016/j.jphs.2018.09.012
关键词
Cichorium glandulosum Boiss. et Huet; Polysaccharides; Non-alcoholic fatty liver disease; Lipid-lowering; Zebrafish
资金
- Applied Basic Research Programs of Qinghai Province [Y229461211]
- Science and Technology Plan Projects in Qinghai Province [2015-ZJ-733]
- A prospective joint research project of Jiangsu Province [BY2016-078-02]
Nonalcoholic fatty liver disease (NAFLD) 1 is the most common chronic liver disease worldwide. Cichorium glandulosum Boiss. et Huet (CG) is a common traditional Uighur medicine, and it has been widely used as active therapy on various hepatic diseases. Recently, lipid-lowering effect has been revealed on CG. Polysaccharides are principal component of CG which could be the possible lipid-lowering compound in CG. In this study, extraction and purification of CG polysaccharides (CGP) was performed, and the lipid regulation effect of CGP was investigated on NAFLD zebrafish model. The results showed that CGP significantly decreased the levels of TC, TG, and decreased the mRNA expression of srebf-1, and fas, increased the expression of pparab. The findings suggest that the lipid-lowering effects of CGP mainly depend on facilitation of lipolysis (mainly beta-oxidation) or inhibition of lipogenesis. Furthermore, CGP could prevent and causes the regression of steatosis in NAFLD via its lipid metabolism regulation effect. (c) 2018 The Authors. Production and hosting by Elsevier B. V. on behalf of Japanese Pharmacological Society.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据